GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 2,380.00
+30.00 (1.28%)
At close: Aug 11, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 93.75 billion as of August 12, 2026. Its market cap has increased by 66.24% in one year.
Market Cap
93.75B
Enterprise Value
74.00B
Revenue
10.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,380.00
ChartMarket Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 93.75B, a decrease of -35.63%. That is a compound annual growth rate of -8.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 93.75B | -19.68% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 269.69B |
| 3billion | 193.48B |
| Cytogen | 79.13B |
| Protia | 65.69B |
| Inventera | 61.67B |
| GC Medical Science | 60.01B |
| HLB Panagene | 50.35B |
| Seoulin Bioscience | 40.55B |